P2Y1 Agonist HIC in Combination with Androgen Receptor Inhibitor Abiraterone Acetate Impairs Cell Growth of Prostate Cancer

0
10
Researchers evaluated the combinatorial effect of HIC with abiraterone acetate targeted on androgen receptor on the inhibition of prostate cancer cells.
[Apoptosis]
Full Article